Skip to content

All Press Releases

PILA PHARMA CEO explains potential of “chili receptor” as diabetes therapy

Dr. Dorte Gram, CEO of PILA PHARMA AB, one of Sweden’s youngest biotech companies, talks to Mike Ward, global director of content for Informa Pharma Intelligence’s insights portfolio, about PILA’s history, its novel diabetes technology and why we should keep an eye on its lead asset that will be taking off with clinical studies in the near future. PILA owns…

Read more

Contact us

Subscription for press releases
Back To Top